Bharat Immunologicals Debt to Equity

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.20  0.95  4.47%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Debt to Equity Analysis

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Bharat Immunologicals 
D/E 
 = 
Total Debt 
Total Equity 
 = 
0.50 times

About Debt to Equity

High Debt to Equity ratio typically indicates that a firm has been barrowing aggressive to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.
Compare to competition
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd has Debt to Equity of 0.5 times. This is much higher than that of the sector, and significantly higher than that of Debt to Equity industry, The Debt to Equity for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Debt to Equity Comparison
Bharat Immunologicals is currently under evaluation in debt to equity category among related companies.

Did you try this?

Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  Next  Launch Portfolio Rebalancing

Fundamental Indicators

Current Bharat Immunologicals financial ratios